Evidence summaries: new medicines-interim process statement
This interim process statement has been produced to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs. These procedures are designed to ensure that a robust, quali...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London
National Institute for Health and Care Excellence (NICE)
1 June 2012, 2012
|
| Series: | Process and methods guides
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This interim process statement has been produced to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs. These procedures are designed to ensure that a robust, quality-assured, commentary is developed for the NHS in an open, transparent and timely way, with appropriate input from key groups. This interim process statement of ESNMs will be superseded when the final process guide is issued later in 2012, following engagement and discussions with key groups |
|---|---|
| Item Description: | "This is not the current process. From May 2013, evidence summaries: new medicines were developed using the integrated process statement"--PDF page 2 |
| Physical Description: | 1 PDF file (15 pages) |
| ISBN: | 9781473119000 |